Browsing Technical documents and research evidence on COVID-19 by Title
Now showing items 939-958 of 1749
-
Long-term clinical outcomes in survivors of coronavirus outbreaks after hospitalization or ICU admission: a systematic review and meta-analysis of follow-u studies
(2020-04-22)Objective: To determine the long-term clinical problems in adult survivors of coronavirus (CoV) infection [Coronavirus disease 2019 (COVID-19), Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome ... -
Long-term clinical outcomes in survivors of SARS and MERS
(2020-07-20)Citation: Ahmed H, Patel K, Greenwood DC, et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: ... -
Longitudinal association between markers of liver injury and mortality in COVID‐19 in China
(2020-05-02)Coronavirus disease 2019 (COVID‐19) is a new infectious disease. To reveal the hepatic injury related to this disease and its clinical significance, we conducted a multicenter retrospective cohort study that included 5,771 ... -
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
(2020-04-18)Background: The dynamic changes of lymphocyte subsets and cytokines profiles of patients with novel coro- navirus disease (COVID-19) and their correlation with the disease severity remain unclear. Methods: Peripheral blood ... -
Longitudinal laboratory testing tied to PCR diagnostics in COVID-19 patients reveals temporal evolution of distinctive coagulopathy signatures
(2020-05-23)Temporal inference from laboratory testing results and their triangulation with clinical outcomes as described in the associated unstructured text from the provider notes in the Electronic Health Record (EHR) is integral ... -
Lopinave/Litonawe (LPV/r) reduced mortality in studies of SARS and MERS: uncertain if it is effective for patients with COVID-19
(2020-03-20)What is this? Like COVID-19, severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) are acute respiratory diseases caused by a coronavirus. Antiviral therapy with Lopinave/Litonawe (LPV/r) ... -
Lopinavir-ritonavir alone or combined with arbidol in the treatment of 73 hospitalized patients with COVID-19: a pilot retrospective study
(2020-04-29)Objectives: This study aimed to evaluate the antiviral efficacy of lopinavir/ritonavir alone or combined with arbidol in the treatment of hospitalized patients with common coronavirus disease-19 (COVID-19). Methods: In ... -
Lopinavir-ritonavir for COVID-19: A living systematic review
(2020-07-15)Objective: Provide a timely, rigorous, and continuously updated summary of the evidence on the role of lopinavir/ritonavir in the treatment of patients with COVID-19. Methods: We conducted searches in the special L·OVE ... -
Lopinavir/ritonavir: A rapid review of effectiveness in COVID-19
(2020-04-14)There are currently no pharmacological treatments for COVID-19. Due to the urgent need for effective treatments, there has been increased interest in re-purposing currently available drugs for immediate use. The antiretroviral ... -
Low blood sodium increases risk and severity of COVID-19: a systematic review, meta-analysis and retrospective cohort study
(2020-05-22)Background Novel coronavirus (SARS-CoV-2) infects human lung tissue cells through angiotensin-converting enzyme-2 (ACE2), and the body sodium is an important factor for regulating the expression of ACE2. Through a systematic ... -
Lung ultrasound findings in patients with novel SARS-CoV2
(2020-05-21)Background: Over 2 million people worldwide have been infected with Severe Acute Respiratory Distress Syndrome Corona Virus 2 (SARS CoV2). Lung ultrasound has been proposed to diagnose and it. However, little is known about ... -
Macrolides for the treatment of COVID-19: a living, systematic review
(2020-12-14)Objective: This living, systematic review aims to provide a timely, rigorous, and continuously updated summary of the evidence available on the role of macrolides for treating patients with COVID-19. Design: A living, ... -
Magnetic resonance imaging findings in Guillain-Barre syndrome caused by Zika virus infection
(2016-06)The recent Zika virus infection (Zika) epidemic in Brazil has been associated with neurological anomalies, including an increase in the number of cases of microcephaly and, more recently, Guillain-Barré syndrome (GBS) [1, ... -
Maintaining Essential Services for People Living with Noncommunicable Diseases during COVID-19
(2020-07-20)The COVID-19 pandemic has had an extraordinary impact on people, economies, and health services. For people living with noncommunicable diseases (NCDs), the impact has included disruptions in access to health services at ... -
Male predisposition to severe COVID-19: Review of evidence and potential therapeutic prospects
(2020-09-18)The severe form of COVID-19 has significant sex disparities, with high fatalities commonly reported among males than females. The incidence of COVID-19 has also been higher in males compared with their female counterparts. ... -
Male-to-Male Sexual Transmission of Zika Virus - Texas, January 2016
(2016-06)Zika virus infection has been linked to increased risk for Guillain-Barré syndrome and adverse fetal outcomes, including congenital microcephaly. In January 2016, after notification from a local health care provider, an ... -
Management of coexisting conditions in the context of COVID-19
(2021-03-18)This page summarises important considerations for the care of people with co-existing medical conditions during the COVID-19 pandemic. Key points from guidance and position statements are summarised for each condition, and ... -
Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation
(2020-04-10)Annually, around 850 liver transplantation is performed in Beijing, China. Recently, the new coronavirus pneumonia (COVID-19) caused by 2019 novel coronavirus (2019-nCoV) has affected nearly 200 countries worldwide. 2019-nCov ... -
Management of Critically Ill Adults With COVID-19
(2020-03-26)Guideline title Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults With COVID-19. Developer Surviving Sepsis Campaign (SSC). Release date March 23, 2020. Target population Critically ill adults ... -
Management of ill travellers at Points of Entry (international airports, seaports, and ground crossings) in the context of COVID-19, Interim guidance 19 March 2020
(2020-03-19)Background: Under the International Health Regulations (IHR), the public health authorities at points of entry—international ports, airports, and ground crossings—are required to establish effective contingency plans and ...